Raymond James Financial Services Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Raymond James Financial Services Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,028	Closed	-$488K	–	3413
2021 Q1	$488K	Sell	7,028 -486	-6%	-$37.4K	﹤0.01%	2307
2020 Q4	$577K	Sell	7,514 -824	-10%	-$61.8K	﹤0.01%	2049
2020 Q3	$624K	Buy	+8,338	New	+$556K	﹤0.01%	1835
2019 Q4	–	Sell	-4,960	Closed	-$227K	–	2976
2019 Q3	$227K	Buy	4,960 +75	+2%	+$4.22K	﹤0.01%	2408
2019 Q2	$286K	Buy	+4,885	New	+$252K	﹤0.01%	2300
2017 Q2	–	Sell	-3,635	Closed	-$53K	–	2595
2017 Q1	$53K	Buy	3,635 +990	+37%	+$14.7K	﹤0.01%	2312
2016 Q4	$38K	Hold	2,645	–	–	﹤0.01%	2254
2016 Q3	$46K	Buy	2,645 +230	+10%	+$3.81K	﹤0.01%	2210
2016 Q2	$41K	Sell	2,415 -1	-0%	-$18	﹤0.01%	2188
2016 Q1	$48K	Buy	+2,416	New	+$38.7K	﹤0.01%	1971
2013 Q3	–	Sell	-6,745	Closed	-$519K	–	991
2013 Q2	$519K	Buy	+6,745	New	+$551K	0.02%	845

Other funds holding ARNA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James Financial Services Advisors's ARNA Position: Q2 2021 in Review

Raymond James Financial Services Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2021, closing a stake of 7,028 shares — an estimated $488K sold.

Raymond James Financial Services Advisors first reported a position in ARNA in Q2 2013 and held it in 11 quarters. The position peaked at $624K in Q3 2020. 237 funds tracked by Wall St. Rank hold ARNA as of Q2 2021.

Raymond James Financial Services Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q2 2021 after selling out during the quarter.
Raymond James Financial Services Advisors sold 7,028 Arena Pharmaceuticals Inc shares in Q2 2021, an estimated $488K.
Raymond James Financial Services Advisors first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 11 quarters.
Raymond James Financial Services Advisors's Arena Pharmaceuticals Inc position peaked at $624K in Q3 2020.
237 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2021.

Based on Raymond James Financial Services Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.